NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

35.44

-0.30 (-0.84%)

At close: May 22, 2026, 4:00 PM EDT

36.60

+1.16 (3.27%)

After-hours: May 22, 2026, 4:58 PM EDT

NAMS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	457.61	490	771.74	340.45	467.73	60.37
Short-Term Investments	178.5	146.24	62.45	-	-	-
Cash & Short-Term Investments	636.11	636.24	834.19	340.45	467.73	60.37
Cash Growth	-21.32%	-23.73%	145.03%	-27.21%	674.73%	-
Other Receivables	-	-	4.95	-	-	-
Total Trade Receivables	-	-	4.95	-	-	-
Other Current Assets	21.94	39.46	24.27	6.34	10.25	6.57
Total Current Assets	658.04	675.7	863.41	346.79	477.98	66.95
Net Property, Plant & Equipment	0.4	0.57	0.67	0.1	0.15	0.22
Other Intangible Assets	0.38	0.41	0.53	88.7	88.7	-
Long-Term Investments	71.24	92.61	-	-	-	-
Other Long-Term Assets	2.59	-	-	0.04	0.16	0.82
Total Assets	732.64	769.28	864.62	435.62	566.99	67.98
Accounts Payable	8.09	8.97	4.74	16.92	11.85	11.17
Accrued Expenses	5.09	15.42	13.61	14.88	7.88	-
Current Portion of Leases	0.02	0.14	0.25	0.06	0.07	0.06
Unearned Revenue	3.99	3.99	6.01	8.94	13.87	-
Other Current Liabilities	50.23	57.27	82.31	12.57	4.15	-
Total Current Liabilities	67.42	85.79	106.92	53.38	37.82	11.24
Long-Term Leases	-	0.07	0.2	-	0.06	0.13
Other Long-Term Liabilities	-	-	-	8.81	12.31	-
Total Long-Term Liabilities	-	0.07	0.2	8.81	12.37	0.13
Total Liabilities	67.42	85.85	107.12	62.18	50.2	11.36
Common Stock	14.59	14.28	13.44	10.17	10.06	95.38
Additional Paid-in Capital	1,457	1,427	1,298	670.78	635.64	0.67
Accumulated Other Comprehensive Income	4.22	4.79	4.47	0.47	0.47	-
Retained Earnings	-810.83	-762.39	-558.57	-307.98	-129.37	-39.43
Shareholders' Equity	665.22	683.43	757.5	373.44	516.79	56.62
Total Liabilities & Equity	732.64	769.28	864.62	435.62	566.99	67.98
Total Debt	0.02	0.2	0.45	0.06	0.13	0.19
Net Cash (Debt)	636.08	636.04	833.74	340.39	467.6	60.19
Net Cash Growth	0.01%	-23.71%	144.94%	-27.21%	676.92%	-
Net Cash Per Share	5.31	5.37	8.84	4.14	24.65	2.55
Book Value	665.22	683.43	757.5	373.44	516.79	56.62
Book Value Per Share	5.55	5.77	8.03	4.55	27.25	2.40
Tangible Book Value	664.85	683.02	756.97	284.74	428.09	56.62
Tangible Book Value Per Share	5.55	5.77	8.02	3.47	22.57	2.40

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q